Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma
Richard B. Wilder, Maria A. Rodriguez, Chul S. Ha, Barbara Pro, Mark A. Hess, Fernando Cabanillas, James D. Cox
Profundice en los temas de investigación de 'Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma'. En conjunto forman una huella única.